Function
This enzyme catalyzes the addition and repair of the conserved 3'-CCA sequence essential for amino acid attachment to the 3' terminus of tRNA molecules, utilizing CTP and ATP as substrates. This specific isoform adds two C residues (CC-) to the 3' terminus of tRNA molecules instead of a complete CCA end, as isoform 1 does (in vitro).
Gene References Into Functions
- In vitro studies on disease-linked variants of human tRNA nucleotidyltransferase have revealed decreased thermal stability and altered catalytic activity. PMID: 29454993
- Patient-specific induced pluripotent stem cells (iPSCs) and iPSC-derived retinal organoids from dermal fibroblasts of patients with molecularly confirmed TRNT1-associated retinitis pigmentosa were used in research. PMID: 28390992
- Data indicates that disease-causing mutations in patient-derived fibroblasts do not affect the subcellular localization of TRNT1 and exhibit no gross morphological differences compared to control cells. PMID: 27317422
- This research expands the ocular and systemic phenotypes associated with mutations in TRNT1, highlighting phenotypic variability and emphasizing the need for ophthalmic review of these patients. PMID: 27389523
- Two non-syndromic retinitis pigmentosa pedigrees with segregating mutations in TRNT1 were studied. PMID: 26494905
- The clinical phenotypes associated with TRNT1 mutations are primarily attributed to impaired mitochondrial translation, arising from defective CCA addition to mitochondrial tRNA(Ser(AGY)). PMID: 25652405
- A model of action is proposed, suggesting that motif C acts as a flexible spring element modulating the relative orientation of the enzyme's head and body domains to accommodate the growing 3'-end of the tRNA. PMID: 25849199
- The discriminator base serves as a crucial substrate recognition element for tRNA nucleotidyltransferases. PMID: 25958396
- Tandem CCA addition is not a result of a modified enzymatic activity specific to unstable RNAs. It is instead a consequence of the natural activity of the CCA-adding enzyme on a substrate with increased conformational flexibility. The CCA-adding enzyme has the ability to trigger the degradation of potentially detrimental small RNAs and tRNAs. PMID: 25640237
- Patient-associated TRNT1 mutations lead to partial loss of function of TRNT1, resulting in metabolic defects in both mitochondria and cytosol, which can account for the phenotypic pleiotropy. PMID: 25193871
- Human gene transcript CGI-47 (#AF151805) was cloned and encodes a bona fide CCA-adding enzyme, not a poly(A) polymerase. PMID: 11727826
- The crystal structure reveals a four-domain architecture with a cluster of conserved residues forming a positively charged cleft between the first two domains. PMID: 12729736
- These findings strongly suggest that the splice variant of the human CCA-adding enzyme is expressed in the cell, although its in vivo function remains unclear. PMID: 17204286
- TRNT1 is an RNA polymerase that adds a CCA sequence to the 3' terminal of tRNA. This reaction has been termed Vice-Anchored Knock-in and Lock Dynamics. [review] PMID: 18575231
Show More
Hide All
Involvement In Disease
Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD); Retinitis pigmentosa and erythrocytic microcytosis (RPEM)
Protein Families
TRNA nucleotidyltransferase/poly(A) polymerase family
Subcellular Location
Mitochondrion.